| Literature DB >> 27737600 |
Antonio L Teixeira1, Haitham Salem1, Benicio N Frey2,3, Izabela G Barbosa4, Rodrigo Machado-Vieira5.
Abstract
INTRODUCTION: Bipolar disorder is a chronic and disabling mood disorder with a complex pathophysiological basis. A significant percentage of patients do not receive correct diagnosis which directly influences therapeutic response, rendering recovery troublesome. There is a long-standing need for proper non-clinically based tools for diagnosis, treatment selection and follow-up of such patients. Areas covered: In the past decade, the scientific community has shown a great interest in biomarker development. Here, we highlight the different potential biomarkers and we discuss their feasibility and their possible clinical relevance. Expert commentary: To date, despite the major ongoing trials and consortia with promising future perspectives, no reliable biomarker of bipolar disorder has been fully defined.Entities:
Keywords: Bipolar disorder; biomarkers; genomic analysis; neuroimaging; peripheral markers
Mesh:
Substances:
Year: 2016 PMID: 27737600 DOI: 10.1080/14737159.2016.1248413
Source DB: PubMed Journal: Expert Rev Mol Diagn ISSN: 1473-7159 Impact factor: 5.225